Abstract
Previous work (Wheeler et al, Gene Therapy 1999; 6: 271–281) has shown that plasmid DNA can be entrapped in ‘stabilized plasmid-lipid particles’ (SPLP) containing the fusogenic lipid dioleoylphosphatidylethanolamine (DOPE), low levels (5–10 mol%) of cationic lipid, and stabilized by a polyethyleneglycol (PEG) coating. The PEG moieties are attached to a ceramide anchor containing an arachidoyl acyl group (PEG-CerC20). These SPLP exhibit low transfection potencies in vitro, due in part to the long residence time of the PEG-CerC20 on the SPLP surface. In this work we employed SPLP stabilized by PEG attached to ceramide containing an octanoyl acyl group (PEG-CerC8), which is able to quickly exchange out of the SPLP, to develop systems that give rise to optimized in vitro and in vivo (regional) transfection. A particular objective was to achieve cationic lipid contents that give rise to maximum transfection levels. It is shown that by performing the dialysis procedure in the presence of increasing concentrations of citrate, SPLP containing up to 30 mol% of the cationic lipid dioleoydimethylammonium chloride (DODAC) could be generated. The SPLP produced could be isolated from empty vesicles by sucrose density gradient centrifugation, and exhibited a narrow size distribution (62 ± 8 nm, as determined by freeze–fracture electron microscopy) and a high plasmid-to-lipid ratio of 65 μg/μmol (corresponding to one plasmid per particle) regardless of the DODAC content. It was found that isolated SPLP containing 20–24 mol% DODAC resulted in optimum transfection of COS-7 and HepG2 cells in vitro, with luciferase expression levels comparable to those achieved for plasmid DNA–cationic lipid complexes. In vivo studies employing an intraperitoneal B16 tumor model and intraperitoneal administration of SPLP also demonstrated maximum luciferase expression for DODAC contents of 20–24 mol% and significantly improved gene expression in tumor tissue as compared with complexes. We conclude that SPLP stabilized by PEG-CerC8 and containing 20–24 mol% cationic lipid are attractive alternatives to plasmid DNA–cationic lipid complexes for regional gene therapy applications.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Felgner PL et al. Lipofection: a highly efficient, lipid-mediated DNA-transfection procedure Proc Natl Acad Sci USA 1987 84: 7413–7417
Gao X, Huang L . Cationic liposome-mediated gene transfer Gene Therapy 1995 2: 710–722
Chonn A, Cullis PR . Recent advances in liposome technologies and their applications for systemic gene delivery Adv Drug Del Rev 1998 30: 73–83
Hofland HEJ, Shephard L, Sullivan SM . Formation of stable cationic lipid/DNA complexes for gene transfer Proc Natl Acad Sci USA 1996 93: 7305–7309
Felgner JH et al. Enhanced gene delivery and mechanism studies with a novel series of cationic lipid formulations J Biol Chem 1994 269: 2550–2561
Zabner J et al. Cellular and molecular barriers to gene transfer by a cationic lipid J Biol Chem 1995 270: 18997–19007
Gao X, Huang L . A novel cationic liposome reagent for efficient transfection of mammalian cells Biochem Biophys Res Comm 1991 179: 280–285
Hong K, Zheng W, Baker A, Papahadjopoulos D . Stabilization of cationic liposome-plasmid DNA complexes by polyamines and poly(ethylene glycol)-phospholipid conjugates for efficient in vivo gene delivery FEBS Lett 1997 400: 233–237
Thierry AR et al. Systemic gene therapy: biodistribution and long-term expression of a transgene in mice Proc Natl Acad Sci USA 1995 92: 9742–9746
Hofland HJ et al. In vivo gene transfer by intravenous administration of stable cationic lipid/DNA complex Pharmaceut Res 1997 14: 742–749
Templeton NS et al. Improved DNA:liposome complexes for increased systemic delivery and gene expression Nature Biotech 1997 15: 647–652
Huang L, Li S . Liposomal gene delivery: a complex package Nature Biotech 1997 15: 620–621
Harrison GS et al. Optimization of gene transfer using cationic lipids in cell lines and primary human CD4+ and CD34+ hematopoietic cells Biotechniques 1995 19: 816–823
Li S, Huang L . In vivo gene transfer via intravenous administration of cationic lipid-protamine–DNA (LPD) complexes Gene Therapy 1997 4: 891–900
Wheeler JJ et al. Stabilized plasmid-lipid particles: construction and characterization Gene Therapy 1999 6: 271–281
Holland JW, Cullis PR, Madden TD . Poly(ethleneglycol)-lipid conjugates promote bilayer formation in mixtures of non-bilayer forming lipids Biochemistry 1996 35: 2610–2617
Holland JW, Hui C, Cullis PR, Madden TD . Poly(ethyleneglycol)-lipid conjugates regulate the calcium-induced fusion of liposomes composed of phosphatidylethanolamine and phosphatidylserine Biochemistry 1996 35: 2618–2624
Holland JW et al. Programmable fusion between cationic liposomes and a eucaryotic plasma membrane J Biol Chem 1999 (submitted)
Hope MJ, Bally MB, Webb G, Cullis PR . Production of large unilamellar vesicles by a rapid extrusion procedure. Characterization of size distribution, trapped volume and ability to maintain a membrane potential Biochim Biophys Acta 1985 812: 55–65
Chonn A, Semple SC, Cullis PR . Association of blood proteins with large unilamellar liposomes in vivo. Relation to circulation lifetimes J Biol Chem 1992 267: 18759–18765
Mayer LD, Hope MJ, Cullis PR, Janoff AS . Solute distributions and trapping efficiencies observed in freeze-thawed multilamellar vesicles Biochim Biophys Acta 1985 817: 193–196
Mui BLS, Cullis PR, Evans EA, Madden TD . Osmotic properties of large unilamellar vesicles prepared by extrusion Biophys J 1993 64: 443–453
Monck M et al. Stabilized plasmid-lipid particles for systemic gene therapy Gene Therapy (submitted)
Ollivon M, Eildelman O, Blumenthal R, Walter A . Micelle–vesicle transition of egg phosphatidylcholine and octyl glucoside Biochemistry 1988 27: 1695–1703
Szoka F Jr, Papahadjopoulos D . Comparative properties and methods of preparation of lipid vesicles (liposomes) Ann Rev Biophys Bioeng 1980 9: 467–508
Vinson PK, Talmon Y, Walter A . Vesicle–micelle transition of phosphatidylcholine and octyl glucoside elucidated by cryo-transmission electron microscopy Biophys J 1989 56: 669–681
Mok KWC, Lam AMI, Cullis PR . Stabilized plasmid-lipid particles: factors influencing DNA entrapment and transfection properties Biochim Biophys Acta (in press)
Webb MS et al. Comparison of different hydrophobic anchors conjugated to poly(ethyleneglycol): effects on the pharmacokinetics of liposomal vincristine Biochim Biophys Acta 1998 1372: 272–282
Birnboim HC, Doly J . A rapid alkaline extraction procedure for screening recombinant plasmid DNA Nucleic Acids Res 1979 7: 1513–1522
Sambrook J, Fritsch EF, Maniatis T . Extraction and purification of plasmid DNA. In: Ford N, Nolan C, Ferguson M (eds) Molecular Cloning, 2nd edn Cold Spring Harbor Laboratory Press: New York 1989 1.38–1.39
Acknowledgements
We thank Drs Z Wang and S Ansell (Inex Pharmaceuticals) for providing PEG-ceramides and DODAC, respectively. We also acknowledge Dr K Wong (Department of Biochemistry and Molecular Biology, University of British Columbia) for performing the freeze–fracture electron microscopy studies and J Thompson and C Giesbrecht (Inex Pharmaceuticals) for providing plasmid.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Zhang, Y., Sekirov, L., Saravolac, E. et al. Stabilized plasmid-lipid particles for regional gene therapy: formulation and transfection properties. Gene Ther 6, 1438–1447 (1999). https://doi.org/10.1038/sj.gt.3300965
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.gt.3300965
Keywords
This article is cited by
-
Exploring the HYDRAtion method for loading siRNA on liposomes: the interplay between stability and biological activity in human undiluted ascites fluid
Drug Delivery and Translational Research (2017)
-
Very Long Chain N 4 ,N 9 -Diacyl Spermines: Non-Viral Lipopolyamine Vectors for Efficient Plasmid DNA and siRNA Delivery
Pharmaceutical Research (2009)
-
Development of a novel systemic gene delivery system for cancer therapy with a tumor-specific cleavable PEG-lipid
Gene Therapy (2007)
-
Lipid-based Nanoparticles for Nucleic Acid Delivery
Pharmaceutical Research (2007)
-
Cerasome as an infusible and cell-friendly gene carrier: synthesis of cerasome-forming lipids and transfection using cerasome
Nature Protocols (2006)